共 9 条
[1]
Tobinai K., Minato K., Ohtsu T., Mukai K., Kagami Y., Miwa M., Watanabe S., Shimoyama M., Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma, Blood, 72, pp. 1000-1006, (1988)
[2]
Siegert W., Agthe A., Griesser H., Schwerdtfeger R., Brittinger G., Engelhard M., Kuse R., Tiemann M., Lennert K., Huhn D., Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group, Ann Intern Med, 117, pp. 364-370, (1992)
[3]
Pautier P., Devidas A., Delmer A., Dombret H., Sutton L., Zini J.M., Nedelec G., Molina T., Marolleau J.P., Brice P., Angioimmunoblastic-like T-cell non-Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature, Leuk Lymphoma, 32, pp. 545-552, (1999)
[4]
Federico M., Rudiger T., Bellei M., Et al., Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project, J Clin Oncol, 31, 2, pp. 240-246, (2013)
[5]
Mundy G., Edwards J., PTH-Related Peptide (PTHrP) in Hypercalcemia, J Am Soc Nephrol, 19, 4, pp. 672-675, (2008)
[6]
Hewison M., Kantorovich V., Liker H., Et al., Vitamin D-Mediated Hypercalcemia in Lymphoma: Evidence for Hormone Production by Tumor-Adjacent Macrophages, J Bone Miner Res, 18, 3, pp. 579-582, (2003)
[7]
Tebben P., Singh R., Kumar R., Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment, Endocr Rev, 37, 5, pp. 521-547, (2016)
[8]
Dogan A., Attygalle A., Kyriakou C., Angioimmunoblastic T-cell lymphoma, Br J Haematol, 121, 5, pp. 681-691, (2003)
[9]
Iannitto E., Ferreri A., Minardi V., Tripodo C., Kreipe H., Angioimmunoblastic T-cell lymphoma, Crit Rev Oncol Hematol, 68, 3, pp. 264-271, (2008)